Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-134414
Filing Date
2016-07-29
Accepted
2016-07-29 14:36:18
Documents
1
Period of Report
2016-07-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3956
  Complete submission text file 0001209191-16-134414.txt   5312
Mailing Address C/O IDENIX PHARMACEUTICALS, INC. 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address
Arkowitz David (Reporting) CIK: 0001296999 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37718 | Film No.: 161793577

Mailing Address 86 SOUTH STREET HOPKINTON MA 01748
Business Address 86 SOUTH STREET HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Issuer) CIK: 0001566373 (see all company filings)

EIN.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations